Health Care [ 5/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology.
It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023.
Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 29, 24 | -2.93 Decreased by -1.44 K% | - |
| Aug 12, 24 | -25.78 Decreased by -14.22 K% | - |
| May 20, 24 | -0.50 Decreased by -178.89% | -0.21 Decreased by -139.05% |
| Mar 7, 24 | -40.05 Decreased by -19.92 K% | - |
| Nov 9, 23 | -0.19 Increased by +29.63% | -0.19 |
| Aug 14, 23 | -0.18 Increased by +50.00% | -0.12 Decreased by -50.00% |
| May 15, 23 | -0.18 Increased by +47.06% | -0.20 Increased by +10.00% |
| Mar 9, 23 | -0.20 Decreased by -400.00% | -0.25 Increased by +20.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 406.86 K Increased by +N/A% | -3.83 M Increased by +28.42% | Decreased by -940.72% Decreased by N/A% |
| Jun 30, 24 | 704.85 K Increased by +N/A% | -14.31 M Decreased by -108.39% | Decreased by -2.03 K% Decreased by N/A% |
| Mar 31, 24 | 700.43 K Increased by +N/A% | -11.12 M Decreased by -290.59% | Decreased by -1.59 K% Decreased by N/A% |
| Dec 31, 23 | 58.47 K Increased by +N/A% | -22.35 M Decreased by -594.57% | Decreased by -38.23 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -5.35 M Decreased by -38.28% | Decreased by N/A% - |
| Jun 30, 23 | 0.00 Decreased by N/A% | -6.87 M Decreased by -60.98% | Decreased by N/A% - |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.85 M Decreased by -37.48% | Decreased by N/A% - |
| Dec 31, 22 | 0.00 Decreased by N/A% | -3.22 M Decreased by -167.41% | Decreased by N/A% - |